CytoReason and Ferring Pharmaceuticals announced a collaboration that pairs CytoReason’s artificial intelligence (AI)-based computational model of the human body with Ferring’s expertise in inflammatory bowel disease (IBD). The purpose is to develop cell-based disease models to accelerate drug discovery and reduce development costs.
In a groundbreaking study, scientists at Harvard University identified an enzyme that seems to dictate the limits of human physical performance.
Coronavirus Transmission: Where the Virus Goes in the Body and How SARS-CoV-2 is Spread
ACE2 (angiotensin-converting enzyme-2), Coronavirus Disease 2019 (COVID-19), Coronavirus Infections, Dr. Anthony Fauci (Director), Human Body, Medical Journals, National Institute of Allergy and Infectious Diseases (NIAID), R&D, Researchers, Science, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), The Lancet, World Health OrganizationA look at which parts of the body the novel coronavirus infects and how SARS-CoV-2 is transmitted from person to person.
Nearly a dozen approved drugs could be effective against COVID-19: study
Antihistamines, Antimalarial, Antipsychotics, Antivirals, Cancer Therapies, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Donald Trump, Drug Compounds, France, Heart tissue, Human Body, Hydroxychloroquine, Proteins, R&D, Remdesivir, Scientists, Studies, United StatesAt least 10 different drug compounds ranging from cancer therapies to antipsychotics and antihistamines may be effective at preventing the new coronavirus from multiplying in the body, according to a multidisciplinary study conducted by a team of scientists in the United States and France.
Results from NASA’s landmark Twins Study reveals some interesting, surprising and reassuring data.
An American astronaut experienced multiple biological changes in space but returned to normal – with some exceptions – after coming back to Earth, according to a study involving twin brothers that shed light on how space flight affects the human body.